Physician profile
William J Badger
NPI 1003935479
$2,159.02
in general payments reported to CMS, 2019-2025
30 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $68.45 · 2021: $168 · 2022: $365 · 2023: $496 · 2024: $481 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $390.30 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $199.20 | 2019-2025 | Lupron Depot |
| Dornier Medtech America, INC | $180.23 | 2022-2023 | Dornier Medtech |
| Urogen Pharma, INC. | $171.53 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $151.72 | 2019-2024 | Advantage System, Spaceoar Vue System - 10ml |
| Teleflex LLC | $107.46 | 2021-2024 | Urolift |
| Axonics, INC. | $93.82 | 2022-2023 | Axonics |
| Janssen Biotech, INC. | $74.49 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $67.46 | 2023-2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $64.50 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $59.40 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $58.99 | 2021-2023 | Aveed, Xiaflex, Edex |
| Ambu INC. | $56.41 | 2024 | |
| Progenics Pharmaceuticals, INC. | $56.16 | 2023-2025 | Pylarify |
| 180 Medical, INC. | $48.49 | 2019-2024 | Gentlecath |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $45.17 | 2021-2023 | Prolaris |
| Stryker Corporation | $37.47 | 2025 | 1788 |
| Tolmar, INC. | $35.59 | 2024 | |
| Astellas Pharma US INC | $35.58 | 2022-2023 | Myrbetriq |
| Ferring Pharmaceuticals INC. | $34.59 | 2020-2024 | Adstiladrin |
| Karl Storz Endoscopy-America | $30.93 | 2021 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Palette Life Sciences, INC. | $19.49 | 2023 | |
| Koelis INC. | $18.54 | 2025 | |
| Janssen Scientific Affairs, LLC | $18.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.09 | 2020 | |
| Neotract INC. | $16.64 | 2019 | |
| Calyxo, INC. | $16.37 | 2024 | Cvac Aspiration System |
| Blue Earth Diagnostics | $15.06 | 2020 | |
| Olympus America INC. | $14.31 | 2024 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Badger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.